GeneDx Holdings (WGS) Change in Acquisitions & Divestments (2023 - 2026)

GeneDx Holdings (WGS) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $12.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 6.26% year-over-year to $12.0 million in Q2 2026; TTM through Jun 2026 was $37.7 million, a 36.08% decrease from a year earlier, with the FY2025 full-year figure at $44.0 million, up 7.09% from the prior year.
• Change in Acquisitions & Divestments was $12.0 million for Q2 2026 at GeneDx Holdings, up from $8.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $16.7 million in Q3 2023 and troughed at $1.1 million in Q4 2023.
• A 4-year average of $10.3 million and a median of $11.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 1364.09% in 2024 and sank 55.34% in 2025, its largest moves.
• Over 4 years, Change in Acquisitions & Divestments stood at $1.1 million in 2023, then surged by 1364.09% to $16.1 million in 2024, then sank by 37.81% to $10.0 million in 2025, then grew by 19.57% to $12.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $12.0 million (Q2 2026), $8.5 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.